NANOBIOTIX (NANO.PA)
FR0011341205 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10K -80.00% | -100.00% | 30.058M | 23.198M -22.82% | 17.85M -23.05% | 76.927M 330.96% | 24.32M -68.39% | 56.616M 132.80% | 104.64M 84.82% | 132.32M 26.45% | N/A | N/A | |
| EBITDA YoY % growth | -51.019M -47.14% | -45.202M 11.40% | -25.266M 44.10% | -45.135M -78.64% | -52.122M -15.48% | -25.296M 51.47% | 14.923M 158.99% | -48.492M -424.95% | 132.03M 372.27% | 188.02M 42.41% | 81.018M -56.91% | 122.69M 51.44% | |
| EBIT YoY % growth | -52.579M -44.34% | -46.702M 11.18% | -26.779M 42.66% | -46.406M -73.29% | -45.716M 1.49% | -17.918M 60.81% | -11.181M 37.60% | -17.67M -58.04% | 71.16M 502.72% | 108.92M 53.06% | 79.852M -26.69% | 121.32M 51.93% | |
| Operating Margin | -525,790.00% | N/A | -89.09% | -200.04% | -256.11% | -23.29% | -45.97% | -31.21% | 68.00% | 82.32% | N/A | N/A | |
| EPS YoY % growth | -1.35 3.57% | N/A -5.70% | -1.08 24.32% | -1.02 5.24% | -1.08 -5.65% | -0.55 49.37% | -0.15 72.44% | -0.72 -375.93% | 2.00 379.20% | 3.02 50.69% | 1.59 -47.34% | 2.33 46.66% |
All data in EUR
| Q4 / 24 | Q2 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.55 -94.89% | -0.38 17.96% | -0.22 58.88% |
| Revenue Q2Q % growth | 11.874M -63.92% | 16.524M 77.89% | 22.236M 87.27% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.283M -1,552.41% | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.46 42.50% | -0.21 | -0.25 | -119.99% |
| Q4 2023 Q2Q % growth | -0.28 | 0.10 | -0.38 | -374.51% |
| Q2 2023 Q2Q % growth | -0.80 -5.26% | -0.73 | -0.07 | -8.93% |
| Q2 2022 Q2Q % growth | -0.76 13.64% | -0.71 | -0.05 | -6.44% |
| Q4 2021 Q2Q % growth | -0.47 4.08% | -0.71 | 0.24 | 34.17% |
| Q2 2021 Q2Q % growth | -0.88 3.30% | -0.66 | -0.22 | -32.73% |
| Q4 2020 Q2Q % growth | -0.49 59.17% | -0.78 | 0.29 | 36.79% |
| Q2 2020 Q2Q % growth | -0.91 20.87% | -1.12 | 0.21 | 18.89% |
| Q4 2019 Q2Q % growth | -1.20 | -0.98 | -0.22 | -22.98% |
| Q2 2019 Q2Q % growth | -1.15 | -0.98 | -0.17 | -17.44% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 9.289M 182.08% | 23.97M | -14.681M | -61.25% |
| Q4 2023 Q2Q % growth | 32.914M | 33.66M | -746K | -2.22% |
| Q2 2023 Q2Q % growth | 3.293M | 2.866M | 427K | 14.90% |
| Q2 2022 Q2Q % growth | -100.00% | 1.02M | -1.02M | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 1.02M | -1.02M | -100.00% |
| Q2 2021 Q2Q % growth | 10K -75.00% | 1.071M | -1.061M | -99.07% |
| Q4 2020 Q2Q % growth | 13K -58.06% | 2.04M | -2.027M | -99.36% |
| Q2 2020 Q2Q % growth | 40K 8.11% | 2.04M | -2M | -98.04% |
| Q4 2019 Q2Q % growth | 31K | 2.011M | -1.98M | -98.46% |
| Q2 2019 Q2Q % growth | 37K | 1.78M | -1.743M | -97.92% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -14.89% |
| Revenue | N/A | N/A | 13.21% | 13.21% |